ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist in Computational Biology at Eikon Therapeutics - ApplyBlast

Senior Scientist in Computational Biology

Eikon Therapeutics

1 month ago

3.3 on Glassdoor

Millbrae, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Eikon Therapeutics is seeking a Senior Scientist in Computational Biology to drive early drug discovery efforts across its target portfolio. The role involves collaborating with diverse discovery scientists to design and evaluate complex experiments while helping shape the adoption of novel experimental systems. This position requires a rigorous analytical thinker who can synthesize data from multiple sources to resolve nuanced scientific questions and ground emerging computational methods in sound biological reasoning.

Responsibilities

Drive development and adoption of novel experimental systems and techniques
Develop and apply analytical approaches and statistical methods for experimental strategies
Analyze multimodal data to evaluate experimental systems and define biological interpretation limits

Skills

Qualifications

PhD in bioinformatics, computational biology, or a quantitative field

About Eikon Therapeutics

eikontx.com

Headquarters

Millbrae, California, United States

Company Size

201-500 employees

Founded

2019

View Profile

Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.